CUD

Pelago Introduces Cannabis Use Disorder Treatment Program

Retrieved on: 
Tuesday, April 23, 2024
Cannabis, Mental Health, Health, Telemedicine, Virtual Medicine, Natural Resources, Managed Care, General Health, SAMHSA, Recreation, Risk, Suds, Tobacco, Research, Depression, Substance Abuse, Clinical, Drug, Cognitive behavioral therapy, Workforce, CUD, Multimedia, CBT, Anxiety, Series, Knowledge, Overalls, Ageing

View the full release here: https://www.businesswire.com/news/home/20240423342287/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240423342287/en/
    Pelago digital cannabis use treatment program (Photo: Business Wire)
    “We’re at an important inflection point in the U.S., with cannabis use disorders on the rise as treatment simultaneously declines,” said Pelago CEO and Co-Founder Yusuf Sherwani, M.D.
  • Immediately following the Series C fundraise, Pelago launched its contingency management program and is now adding cannabis use disorder (CUD) treatment to help employers and health plans address rising rates and costs of substance use.
  • Pelago’s cannabis program is leveraging the first two approaches at launch, along with other key program elements, including physician-led care, personalized CBT, and complex condition management, and will evolve its contingency management program to include cannabis later in 2024.
  • For more information about Pelago's cannabis use disorder treatment program and its existing suite of substance use management solutions, visit www.pelagohealth.com or contact a member of our team .

Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results

Retrieved on: 
Monday, April 1, 2024
Mental Health, Research, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, Science, Oncology, PIN, PNH, Patient, Sale, CUD, Graft-versus-host disease, Investment, Clinical trial, Hemolysis, Calcineurin, Emory University, ASH, Risk, L-DOPA, Thumbay Hospital, Behavior informatics, Trial of the century, Myelodysplastic syndrome, Cancer, Safety, Transplant, LID, DRI, BLA, Corporation, Paroxysmal nocturnal hemoglobinuria, Tardive dyskinesia, Parkinson's disease, Publication, DSM-IV codes, Retirement, FDA, PDE7, LDH, Hematology, Mortality, Hematopoietic stem cell transplantation, Bone marrow failure, Abstract, Society, Pharmacology, Pharmaceutical industry

Net loss from continuing operations was $39.3 million for the 2023 fourth quarter compared to $51.7 million for the prior quarter.

Key Points: 
  • Net loss from continuing operations was $39.3 million for the 2023 fourth quarter compared to $51.7 million for the prior quarter.
  • Total operating expenses for the fourth quarter of 2023 were $39.8 million compared to $48.2 million for the third quarter of 2023.
  • Interest expense during the fourth quarter of 2023 was $7.1 million compared to $7.9 million during the prior quarter.
  • During the fourth quarter of 2023, we earned $3.4 million in interest and other income compared to $4.4 million in the third quarter.

Fortinet Wins Google Cloud Technology Partner of the Year Award for Security – Identity & Endpoint Protection

Retrieved on: 
Tuesday, August 29, 2023
Cloud, Software as a service, Infrastructure as a service, Partnership, XDR, NCC, Attack, University, Financial Times Business Book of the Year Award, Network, World Trade Center (1973–2001), TAA, EVP, Wafaa Bilal, Secure, Google Cloud Platform, Denial-of-service attack, Research, SAP, Certification, Organization, Security, NSE, VPN, NGFW, CUD, Fortinet, Machine learning, Google Cloud, Magic, Education outreach, Ecosystem, Growth, MITRE, Global Outbreak Alert and Response Network, University of Piraeus, WAF, Video game, Network equipment provider

The company has been recognized in the Security – Identity & Endpoint Protection category for its FortiEDR solution, which is SaaS-hosted on Google Cloud and available in the Google Marketplace .

Key Points: 
  • The company has been recognized in the Security – Identity & Endpoint Protection category for its FortiEDR solution, which is SaaS-hosted on Google Cloud and available in the Google Marketplace .
  • Fortinet was recognized for its achievements in the Google Cloud ecosystem, helping joint customers fortify their identity and endpoint protection with the seamless integration of FortiEDR with Google Cloud's Security Command Center.
  • In addition to FortiEDR, Fortinet offers a broad cloud security portfolio for Google Cloud that provides consistent, advanced enterprise security for customers with Google Cloud–based environments.
  • Fortinet FortiFlex can also help Google Cloud customers better optimize their security deployments and spend on Google Cloud.

Omeros Corporation Reports Second Quarter 2023 Financial Results

Retrieved on: 
Wednesday, August 9, 2023
Neurology, Biotechnology, Pharmaceutical, Oncology, Health, FDA, Clinical Trials, Other Health, DSM-IV codes, Survival, Tardive dyskinesia, Bangladesh Technical Education Board, Data analysis, Patent, Investment, Patient, Congress, BLA, Inflammation, Emory University, Therapy, Paroxysmal nocturnal hemoglobinuria, European Hematology Association, Research, Emory, Government, Proteinuria, Kidney International, CUD, Glomerulus, Manuscript, L-DOPA, Hematuria, Safety, Omeros, COVID-19, Inflammation Research, Immunoglobulin A, Fibrosis, PIN, Cancer, PNH, National Institute on Drug Abuse, LID, PDE7, Hemolysis, Complement, Clinical trial, Mannan-binding lectin, Sale, Trial of the century, IgA nephropathy, Corporation, NIDA, Society, C5, Pharmaceutical industry, Reinsurance, Music, Security (finance), Vaccine, Video game, Frontiers, Hematology, Immunology, Agency

“Our team continued building significant shareholder value throughout the second quarter of 2023,” said Gregory A. Demopulos, M.D., Omeros’ chairman and chief executive officer.

Key Points: 
  • “Our team continued building significant shareholder value throughout the second quarter of 2023,” said Gregory A. Demopulos, M.D., Omeros’ chairman and chief executive officer.
  • Total costs and expenses for the second quarter of 2023 were $40.9 million compared to $37.4 million for the second quarter of 2022.
  • Interest expense during the second quarter of 2023 was $7.9 million compared to $4.9 million during the prior year quarter.
  • During the second quarter of 2023, we earned $4.5 million in interest and other income compared to $0.7 million in the prior year quarter.

Apptio Launches Multi-cloud FinOps Innovation for Advanced Cloud Spend Planning and Optimization, Savings Automation, and Kubernetes Integration

Retrieved on: 
Wednesday, June 14, 2023
Cloud, Product marketing, Amazon Web Services, Microsoft, Automation, Forecasting, Organization, Parity, Running, OpenShift, CUD, Google Cloud, Forrester, Here Technologies, AWS, Economics, Video game, Apptio, Azure

BELLEVUE, Wash., June 14, 2023 /PRNewswire/ -- Apptio, the leading technology spend and value management company, today launched new FinOps capabilities to its Cloudability product family, further reducing the complexity of managing and optimizing multi-cloud environments. New releases include expanded rightsizing and optimization recommendations across the major public cloud providers, integration with Red Hat OpenShift Service on AWS, and Cloudability Savings Automation - the updated name and latest version of Cloudwiry, which Apptio acquired in January 2023.

Key Points: 
  • In addition, Apptio recently announced its Cloudability Government offering , and the new Cloudability Financial Planning, currently in beta, that brings Apptio's proven financial planning and forecasting capabilities to multi-cloud deployments.
  • Cloud-native applications and economic pressures are driving a continued rise in public cloud usage, and, subsequently, a rise in FinOps adoption to manage growing cloud costs and complexity.
  • Cloudability Savings Automation maximizes cloud savings by dynamically adjusting a customer's savings instruments, such as Reserved Instances, to fit the pattern of resource usage.
  • To hear more about how Apptio is driving FinOps innovation, register for the FinOps X conference, being held in San Diego, June 27 to 30.

Apptio Launches Multi-cloud FinOps Innovation for Advanced Cloud Spend Planning and Optimization, Savings Automation, and Kubernetes Integration

Retrieved on: 
Wednesday, June 14, 2023
Cloud, Product marketing, Amazon Web Services, Microsoft, Automation, Forecasting, Organization, Parity, Running, OpenShift, CUD, Google Cloud, Forrester, Here Technologies, AWS, Economics, Video game, Apptio, Azure

BELLEVUE, Wash., June 14, 2023 /PRNewswire/ -- Apptio, the leading technology spend and value management company, today launched new FinOps capabilities to its Cloudability product family, further reducing the complexity of managing and optimizing multi-cloud environments. New releases include expanded rightsizing and optimization recommendations across the major public cloud providers, integration with Red Hat OpenShift Service on AWS, and Cloudability Savings Automation - the updated name and latest version of Cloudwiry, which Apptio acquired in January 2023.

Key Points: 
  • In addition, Apptio recently announced its Cloudability Government offering , and the new Cloudability Financial Planning, currently in beta, that brings Apptio's proven financial planning and forecasting capabilities to multi-cloud deployments.
  • Cloud-native applications and economic pressures are driving a continued rise in public cloud usage, and, subsequently, a rise in FinOps adoption to manage growing cloud costs and complexity.
  • Cloudability Savings Automation maximizes cloud savings by dynamically adjusting a customer's savings instruments, such as Reserved Instances, to fit the pattern of resource usage.
  • To hear more about how Apptio is driving FinOps innovation, register for the FinOps X conference, being held in San Diego, June 27 to 30.

ECO Canada expands awareness and partnership opportunities to Trinidad and Guyana

Retrieved on: 
Thursday, May 18, 2023
Canada, Workforce, Bachelor, Accreditation, Environmental science, MODUL University Dubai, Association of Environmental Professionals, Canadian University Dubai, ECO Canada, Government, Certification, Natural Resources, Climate change, Sustainability, CUD, Non-governmental organization, ECO, University of Michigan School for Environment and Sustainability, Associated Training Services, Nursing, Renewable energy, Science, Environment

With over 30 years of experience in providing environmental workforce development solutions, ECO Canada aims to bring its expertise and knowledge to global markets.

Key Points: 
  • With over 30 years of experience in providing environmental workforce development solutions, ECO Canada aims to bring its expertise and knowledge to global markets.
  • Kevin Nilsen, President and CEO of ECO Canada, will be traveling to Guyana and Trinidad on May 20-27, 2023, to discuss the expansion of ECO Canada’s international presence.
  • Under his leadership, ECO Canada has continued to expand its programs and services, including its international partnerships.
  • Travelling with Kevin to the Caribbean is Dr. Yogendra Chaudhry, Vice President of Professional Services at ECO Canada.

SoVT CUD Set to Become First to Reach Universal Broadband Coverage by Year-End With Fidium Fiber Expansion

Retrieved on: 
Wednesday, May 3, 2023
Internet, VoIP, Mobile, Wireless, Technology, Telecommunications, Partnership, Consolidated Communications, Marlboro, Shaftsbury, Vermont, Provisions of the Affordable Care Act, Cud, CUD, Voice over IP, Data-rate units, Community unionism, Consolidated, Property management, Cable television

“We are excited that our communities are taking the final steps for high-speed internet connectivity,” said Eric Hatch, chair of SoVT CUD.

Key Points: 
  • “We are excited that our communities are taking the final steps for high-speed internet connectivity,” said Eric Hatch, chair of SoVT CUD.
  • “In partnering with Consolidated Communications, we have been able to give our communities an advantage to quickly reach universal coverage.
  • “Our partnership with SoVT CUD has helped us bring fiber internet to thousands of unserved and underserved residents of southern Vermont.
  • To learn more about Fidium Fiber availability and pre-order to get updates about fiber expansion, visit FidiumFiber.com .

Omeros Corporation Awarded $6.69 Million Grant from the National Institute on Drug Abuse for its OMS527 Addiction Program

Retrieved on: 
Monday, April 10, 2023
Health, Clinical Trials, General Health, Research, Pharmaceutical, Science, Rat, Human, Nicotine, Peer review, Brain, Bangladesh Technical Education Board, Trial of the century, Crave, Corporation, CUD, Cocaine, National Institute on Drug Abuse, Patient, Drug, NIDA, Behavior informatics, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, PDE7, Food, Safety, Pharmaceutical industry

Omeros Corporation (Nasdaq: OMER) today announced that it has been awarded a grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, to develop Omeros’ lead orally administered compound from its proprietary phosphodiesterase 7 (PDE7) program OMS527 for the treatment of cocaine use disorder (CUD).

Key Points: 
  • Omeros Corporation (Nasdaq: OMER) today announced that it has been awarded a grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, to develop Omeros’ lead orally administered compound from its proprietary phosphodiesterase 7 (PDE7) program OMS527 for the treatment of cocaine use disorder (CUD).
  • Following peer review including leaders in the field from academia and industry, grant funding was awarded on April 7, 2023.
  • Omeros discovered the role of PDE7 in addiction and compulsion and elucidated the associated mechanism of action of PDE7 inhibition.
  • Research reported in this press release was supported by the National Institute on Drug Abuse of the National Institutes of Health under award number U01DA058541.

STALICLA signs Cooperative Research and Development Agreement (CRADA) with US National Institute on Drug Abuse (NIDA) to cover Phase 3 development of mavoglurant in cocaine use disorder

Retrieved on: 
Wednesday, March 8, 2023
Development, DEPI, DSM-IV codes, CUD, NIDA, Cooperative research and development agreement, Patient, CRADA, Public, NIH, Pharmaceutical industry, Novartis

The agreement covers the clinical development program of mavoglurant to treat patients diagnosed with cocaine use disorder (CUD), including a Phase 3 study.

Key Points: 
  • The agreement covers the clinical development program of mavoglurant to treat patients diagnosed with cocaine use disorder (CUD), including a Phase 3 study.
  • NIDA is the lead federal agency supporting scientific research on drug use and addiction to improve individual and public health.
  • Under the terms of the CRADA, NIDA will cover under its own account the Phase 3 trial for mavoglurant, which is slated to enrol up to 330 patients.
  • We have onboarded an exceptional partner in NIDA and we are excited about working together to accelerate mavoglurant towards a new drug application.”